- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01279837
Pharyngocise Dose Response Study
Muscle Preservation and Swallow Function Following Radiotherapy: A Dose Response Study
Study Overview
Detailed Description
In an earlier pilot study, a regime of simple swallowing exercises was identified as useful in maintaining oropharyngeal muscle characteristics as measured by T2 weighted Magnetic Resonance Imaging (MRI) and produced a trend toward improved function for swallowing in patients undergoing radiotherapy for head and neck cancer. The purpose of this current study is to evaluate the dose response of two levels of swallowing exercise intensity on the maintenance of muscle composition and function for swallowing in Head/Neck cancer patients undergoing radiotherapy.
HYPOTHESIS: A program of intensive swallowing exercise (Pharyngocise) will maintain muscle function in the oral cavity and pharynx during radiotherapy, preserving or supporting swallowing function in Head/Neck cancer patients.
STUDY DESIGN: 130 patients with Head/Neck cancer, confirmed by clinical history and exam, will be recruited over a 4 year period. All subjects will undergo an initial baseline work up, including a standardized clinical and instrumental swallowing evaluation, psychosocial scales, nutritional exam, and T2 weighted MRI prior to the first radiation therapy. Subjects will be randomized into 1 of 3 groups:
Group A: Usual care (control) group - patients will receive swallowing and prescribed dietary intervention during the radiotherapy period prescribed by the attending physician.
Group B: High intensity pharyngocise treatment group - patients will receive twice daily swallowing intervention by a speech language pathologist, consisting of the battery of isometric/isotonic exercises.
Group C: Low intensity pharyngocise treatment group - patients will receive a single instructional exercise session on the isometric/isotonic exercises from a Speech Language Pathologist and a practice tape to support home practice of the exercises.
All patients will be treated for approximately 6 weeks and followed for 3 months post treatment. Baseline assessments will be repeated. In addition, daily treatment details, patients perception of current swallowing ability and progress in therapy will be recorded by the Speech Pathologist. Participants will be independently monitored throughout the treatment period by researcher blind to the treatment group assigned, via weekly phone interview sessions. Compliance with the treatment techniques, and the occurrence of any negative endpoints such as occurrence of aspiration pneumonia will be recorded.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32610
- Shands Cancer Center, University of Florida
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Head/Neck cancer of the oropharyngeal or adjacent regions, confirmed by clinical history and exam, with positive cross sectional imaging studies and histopathological biopsy excluding other pathology.
- Planned external beam radiation therapy
- No previous history of non-oral feeding for cancer related illness
- Able to undergo MRI imaging scan
- Patient and physician agreement to enter the study
Exclusion Criteria:
- Planned extensive surgical intervention
- Existence of a co-existing neurological or medical disorder known to cause dysphagia
- Prior radiotherapy or surgery to the head / neck region that could contribute to dysphagia.
- Previous swallowing therapy within four weeks of randomization
- Gross tumor involvement of the oral and pharyngeal muscles obviating adequate MRI measurements of the majority of muscles of interest.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: FACTORIAL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: Usual care
Control (Usual care) group in which patients will receive swallowing and prescribed dietary intervention during the radiotherapy period prescribed by the attending physician.
|
|
EXPERIMENTAL: High Intensity Pharyngocise
Patients receive twice daily swallowing intervention by a speech language pathologist, consisting of the battery of isometric / isotonic exercises.
|
swallowing intervention by a speech language pathologist, consisting of the battery of isometric / isotonic exercises
|
ACTIVE_COMPARATOR: Low Intensity Pharyngocise
Patients will receive a one time only swallowing intervention session by a speech language pathologist, instructing them in the battery of isometric / isotonic exercises plus a home practice instruction digital video tape to support self directed practice of this program at home.
|
swallowing intervention by a speech language pathologist, consisting of the battery of isometric / isotonic exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in T2 Weighted Magnetic Resonance Imaging
Time Frame: at 3 months after treatment
|
T2 Weighted Magnetic Resonance Imaging (MRI) to quantify baseline muscle parameters in the oral cavity and pharynx.
The regions of interest will be identified on images using axial and coronal planes.
Information regarding the muscle volume, composition (fat Vs muscle Vs edema) as reflected by the signal intensity.
|
at 3 months after treatment
|
Clinical swallowing Ability
Time Frame: baseline, 3 weeks, 6 weeks and 3 months post treatment
|
Swallowing ability and method/ type of dietary intake, e.g.
Functional Oral Intake Scale score [F.O.I.S] over the study period
|
baseline, 3 weeks, 6 weeks and 3 months post treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight
Time Frame: baseline, 3 weeks, 6 weeks and 3 months post treatment
|
Weight and Body Mass Index will be calculated.
|
baseline, 3 weeks, 6 weeks and 3 months post treatment
|
Psychosocial functioning
Time Frame: baseline and 3 months post treatment
|
Domain assessments for, quality of life, pain,and fatigue using the Functional Assessment of Cancer Therapy - Head and Neck (FACT-H/N), Pain Disability Index (PDI), Functional Assessment of Cancer Therapy - Anemia (FACT-An) scale, Multidimensional Fatigue Symptom Inventory (MFSI), Profiles of Mood Scale (POMS) and Center for Epidemiologic Studies Depression Scale(CESD).
|
baseline and 3 months post treatment
|
Instrumental swallowing evaluation
Time Frame: baseline and 3 months post treatment
|
Range of swallowing biomechanics measured from endoscopic and fluorographic evaluations.
|
baseline and 3 months post treatment
|
Swallowing Quality of Life
Time Frame: baseline and 3 months post treatment
|
Patient perception of effect of swallowing disability - Swallowing Quality of Life (SWAL QOL) score during the study period.
|
baseline and 3 months post treatment
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RSG-06-103-01(CCE)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dysphagia
-
Morinaga Milk Industry Co., LTDHospital de MataróRecruitingDysphagia | Swallowing Disorder | Dysphagia, Oral Phase | Dysphagia, Esophageal | Dysphagia, OropharyngealSpain
-
All India Institute of Medical Sciences, New DelhiRecruitingOropharyngeal Dysphagia | Dysphagia, Late Effect of Stroke | Transfer Dysphagia | Cricopharyngeus Muscle DysfunctionIndia
-
National Taiwan University HospitalRecruitingDysphagia, Swallowing Function, Diet Modification, Dysphagia Diet, Diet StandardizationTaiwan
-
University of Southern CaliforniaRecruitingDysphagia | Pharyngeal Dysphagia | Oral Pharyngeal DysphagiaUnited States
-
Peter Belafsky, MDTerminatedDysphagia | Oropharyngeal Dysphagia (OPD)United States
-
Atlantic Health SystemRecruitingPost Extubation DysphagiaUnited States
-
University of California, DavisCalifornia Institute for Regenerative Medicine (CIRM); Cook MyoSiteRecruitingOropharyngeal DysphagiaUnited States
-
University of British ColumbiaB.C. Rehabilitation FoundationCompletedThin Liquid DysphagiaCanada
-
Umm Al-Qura UniversityCompleted
-
NestléCompleted
Clinical Trials on Pharyngocise
-
University of FloridaFlorida Department of HealthCompletedHead & Neck CancerUnited States